About ATRS

Antares Pharma, Inc. is a specialty pharmaceutical company focused on the development and commercialization of self-administered parenteral pharmaceutical products using advanced drug delivery auto injection technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in advanced stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), AMAG Pharmaceuticals, Inc. and Pfizer Inc. (Pfizer). Antares Pharma's proprietary products include OTREXUP (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva.
Primary Exchange: NASDAQ
SIC Surgical & Medical Instruments & Apparatus
NAICS Surgical and Medical Instrument Manufacturing

ATRS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ITOT iShares Core S&P Total U.S. Stock Market ETF 20.4 B 2.04474E+10 3,545 3545 0.0% 0 291 K 291162
IWC iShares Microcap ETF 858.7 M 8.58676E+08 1,430 1430 0.12% 0.0012 1.0 M 1005570
IWM iShares Russell 2000 ETF 41.2 B 4.12382E+10 1,985 1985 0.02% 0.0002 8.6 M 8644930
IWO iShares Russell 2000 Growth ETF 8.9 B 8.9462E+09 1,230 1230 0.04% 0.0004 3.6 M 3550410
IWV iShares Russell 3000 ETF 9.3 B 9.30666E+09 2,929 2929 0.0% 0 132 K 132496
XHE SPDR S&P Health Care Equipment 598.4 M 5.9843E+08 69 69 0.36% 0.00361411 2.2 M 2150594
URTY ProShares UltraPro Russell2000 90.2 M 9.0207E+07 1,996 1996 0.0% 4.80665E-05 14 K 14244
UWM ProShares Ultra Russell2000 162.4 M 1.62362E+08 1,996 1996 0.01% 8.30651E-05 29 K 29370
PXSG Invesco Russell 2000 Pure Growth ETF 81.3 M 8.13E+07 300 300 0.4% 0.00402 322 K 321983